{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:58:38Z","timestamp":1791619118367,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M733599"],"award-info":[{"award-number":["2023M733599"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["HDMZ25H300005"],"award-info":[{"award-number":["HDMZ25H300005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["2025ZY01093"],"award-info":[{"award-number":["2025ZY01093"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC2706100"],"award-info":[{"award-number":["2023YFC2706100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejpb.2025.114914","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T05:52:39Z","timestamp":1763272359000},"page":"114914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impact of terminal groups on PLGA degradation rate and their role in sustained release of cyproterone acetate"],"prefix":"10.1016","volume":"218","author":[{"given":"Qien","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7987-8856","authenticated-orcid":false,"given":"Jiantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114914_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114857","article-title":"Long-acting PLGA microspheres: Advances in excipient and product analysis toward improved product understanding","volume":"198","author":"Wan","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114914_b0010","article-title":"Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications","volume":"7","author":"Martins","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2025.114914_b0015","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2025.114914_b0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/ten.teb.2012.0443","article-title":"Physicochemical properties and applications of poly(lactic-co-glycolic acid) for use in bone regeneration","volume":"19","author":"Lanao","year":"2013","journal-title":"Tissue Eng. Part B-Rev."},{"key":"10.1016\/j.ejpb.2025.114914_b0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","article-title":"Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation","volume":"304","author":"Park","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2008.08.012","article-title":"The origins and evolution of \u201ccontrolled\u201d drug delivery systems","volume":"132","author":"Hoffman","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2013a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.04.023","article-title":"Encapsulation and release of doxycycline from electrospray-generated PLGA microspheres: Effect of polymer end groups","volume":"564","author":"Wang","year":"2019","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1208\/s12248-021-00611-y","article-title":"FDA's poly (lactic-co-glycolic acid) research program and regulatory outcomes","volume":"23","author":"Wang","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114914_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120907","article-title":"Effect of polymer source on in vitro drug release from PLGA microspheres","volume":"607","author":"Wan","year":"2021","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0055","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jps.24299","article-title":"Excipient variability and its impact on dosage form functionality","volume":"104","author":"Dave","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114914_b0060","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s13346-021-01023-3","article-title":"Characterization of commercial PLGAs by NMR spectroscopy","volume":"12","author":"Sun","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114914_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with Antiandrogenic Properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ejpb.2025.114914_b0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0000000000001094","article-title":"Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009-2012","volume":"126","author":"Kavanaugh","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejpb.2025.114914_b0075","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s11095-015-1686-2","article-title":"Long-acting injectable hormonal dosage forms for contraception","volume":"32","author":"Wu","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114914_b0080","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jconrel.2021.12.017","article-title":"Coaxial electrospray of uniform polylactide core-shell microparticles for long-acting contraceptive","volume":"341","author":"Tang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0010-7824(73)90163-7","article-title":"Depot-medroxyprogesterone acetate as a contraceptive agent: Return of fertility after discontinuation of use","volume":"8","author":"McDaniel","year":"1973","journal-title":"Contraception"},{"key":"10.1016\/j.ejpb.2025.114914_b0090","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/nprot.2007.391","article-title":"Synthesis of poly(L-lactide) and polyglycolide by ring-opening polymerization","volume":"2","author":"Kaihara","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2025.114914_b0095","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1021\/cr040002s","article-title":"Controlled ring-opening polymerization of lactide and glycolide","volume":"104","author":"Dechy-Cabaret","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2025.114914_b0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2015.08.063","article-title":"A protocol for assay of poly(lactide-co-glycolide) in clinical products","volume":"495","author":"Garner","year":"2015","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.07.018","article-title":"Microencapsulation by solvent evaporation: State of the art for process engineering approaches","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jconrel.2013.05.034","article-title":"The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles","volume":"172","author":"Samadi","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.07.009","article-title":"Plasticizing effect of water on poly(lactide-co-glycolide)","volume":"108","author":"Blasi","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2013.06.035","article-title":"Healing kinetics of microneedle-formed pores in PLGA films","volume":"171","author":"Mazzara","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0125","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jconrel.2020.01.023","article-title":"Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying","volume":"321","author":"Shi","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122566","article-title":"Donepezil accelerates the release of PLGA microparticles via catalyzing the polymer degradation regardless of the end groups and molecular weights","volume":"632","author":"Quan","year":"2023","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jddst.2015.10.009","article-title":"Importance of PLGA microparticle swelling for the control of prilocaine release","volume":"30","author":"Gasmi","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114914_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119339","article-title":"The effect of PLGA molecular weight differences on risperidone release from microspheres","volume":"582","author":"Kohno","year":"2020","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0145","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0142-9612(02)00170-9","article-title":"Why degradable polymers undergo surface erosion or bulk erosion","volume":"23","author":"Burkersroda","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114914_b0150","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1557\/adv.2018.602","article-title":"The influence of pH on the molecular degradation mechanism of PLGA","volume":"3","author":"Machatschek","year":"2018","journal-title":"MRS Adv."},{"key":"10.1016\/j.ejpb.2025.114914_b0155","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/S0032-3861(00)00646-7","article-title":"New insights into the hydrolytic degradation of poly(lactic acid): Participation of the alcohol terminus","volume":"42","author":"de Jong","year":"2001","journal-title":"Polymer"},{"key":"10.1016\/j.ejpb.2025.114914_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.113250","article-title":"Chemical features of the synthesis, degradation, molding and performance of poly(lactic-co-glycolic) acid (PLGA) and PLGA-based articles","volume":"215","author":"Nifant\u2019ev","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejpb.2025.114914_b0165","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.actbio.2011.05.036","article-title":"In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres","volume":"7","author":"Felix Lanao","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2025.114914_b0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/17425247.5.6.615","article-title":"Analysis of initial burst in PLGA microparticles","volume":"5","author":"Allison","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114914_b0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114914_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123017","article-title":"Weibull \u03b2 value for the discernment of drug release mechanism of PLGA particles","volume":"640","author":"Martin-Camacho","year":"2023","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114914_b0185","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1177\/08853282211056937","article-title":"Poly(lactic acid-co-glycolic acid)-based celecoxib extended-release microspheres for the local treatment of traumatic heterotopic ossification","volume":"36","author":"Lin","year":"2022","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ejpb.2025.114914_b0190","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.06.039","article-title":"Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies","volume":"213","author":"Gasmi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0195","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jconrel.2016.08.023","article-title":"Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation","volume":"244","author":"Hirota","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0200","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2016.03.011","article-title":"Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere\/PVA hydrogel composites","volume":"228","author":"Gu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114914_b0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2018.07.044","article-title":"Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight","volume":"286","author":"Mylonaki","year":"2018","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:10:59Z","timestamp":1778559059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125002917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0939641125002917"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114914","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of terminal groups on PLGA degradation rate and their role in sustained release of cyproterone acetate","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114914"}}